243 related articles for article (PubMed ID: 8816577)
1. Oral fluconazole for vaginal candidiasis.
Desai PC; Johnson BA
Am Fam Physician; 1996 Sep; 54(4):1337-40, 1345-6. PubMed ID: 8816577
[TBL] [Abstract][Full Text] [Related]
2. [The treatment of vaginal candidiasis with a single oral dose of fluconazole].
Zlatkov V; Karag'ozov I; Katsarova M
Akush Ginekol (Sofiia); 1991; 30(2):67-70. PubMed ID: 1883053
[TBL] [Abstract][Full Text] [Related]
3. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
Donders G; Bellen G; Byttebier G; Verguts L; Hinoul P; Walckiers R; Stalpaert M; Vereecken A; Van Eldere J
Am J Obstet Gynecol; 2008 Dec; 199(6):613.e1-9. PubMed ID: 18976735
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
Vacheva-Dobrevski R; Kovachev S; Nacheva A; Stoev S; Vasilev N
Akush Ginekol (Sofiia); 2004; 43(1):20-3. PubMed ID: 15168649
[TBL] [Abstract][Full Text] [Related]
5. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses.
Mendling W; Krauss C; Fladung B
Mycoses; 2004 Apr; 47(3-4):136-42. PubMed ID: 15078430
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis.
O-Prasertsawat P; Bourlert A
Sex Transm Dis; 1995; 22(4):228-30. PubMed ID: 7482105
[TBL] [Abstract][Full Text] [Related]
9. [Combined single-day treatment in acute vulvovaginal candidosis].
Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials.
Pitsouni E; Iavazzo C; Falagas ME
Am J Obstet Gynecol; 2008 Feb; 198(2):153-60. PubMed ID: 18068146
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)].
Borisov I; Kolarov G; Bobcheva S; Ivanova A
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():17-20. PubMed ID: 16028398
[TBL] [Abstract][Full Text] [Related]
12. [New study shows probiotics ineffective in prevention of post-antibiotic vaginal candidiasis].
Bern VH
Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1843. PubMed ID: 15559911
[No Abstract] [Full Text] [Related]
13. Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study.
Slavin MB; Benrubi GI; Parker R; Griffin CR; Magee MJ
J Fla Med Assoc; 1992 Oct; 79(10):693-6. PubMed ID: 1460451
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis.
Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Tamaya T
Chemotherapy; 1998; 44(5):364-8. PubMed ID: 9732153
[TBL] [Abstract][Full Text] [Related]
15. One-day therapy for vaginal candidiasis. A review.
Edelman DA; Grant S
J Reprod Med; 1999 Jun; 44(6):543-7. PubMed ID: 10394549
[TBL] [Abstract][Full Text] [Related]
16. FPIN’s clinical inquiries: treatment of recurrent vulvovaginal candidiasis.
Davis JD; Harper AL
Am Fam Physician; 2011 Jun; 83(12):1482-4. PubMed ID: 21671551
[No Abstract] [Full Text] [Related]
17. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
[TBL] [Abstract][Full Text] [Related]
18. Oral fluconazole and vulvovaginal candidiasis: prevention is not always better than cure.
Prescrire Int; 2013 Sep; 22(141):205. PubMed ID: 24171211
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Li T; Zhu Y; Fan S; Liu X; Xu H; Liang Y
Med Mycol; 2015 Jun; 53(5):455-61. PubMed ID: 25877666
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
